Gyre Therapeutics, Inc. (GYRE)

Import this data to Google Sheets with:

=jivedata("GYRE","financials")

Full statements spill as a table. For one cell: =jivedata("GYRE","Revenue") or =jivedata("GYRE","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Gyre Therapeutics, Inc.

GYRE • CIK 0001124105

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$113,450	$105,757	$116,588	$121,294
Cost of Goods and Services Sold	$4,636	$3,884	$5,416	$6,807
Gross Profit	$108,814	$101,873	—	$102,415
Operating Expenses	$176,044	$85,710	$105,101	$149,622
Research and Development Expense	—	$12,024	$13,698	$17,341
Operating Income (Loss)	$-67,230	$16,163	$11,487	$-26,294
Interest Income (Expense), Net	$1,044	$1,547	$1,747	$1,433
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-76,965	$23,218	$14,436	$-24,901
Income Tax Expense (Benefit)	$8,515	$5,320	$4,556	$3,378
Net Income (Loss) Attributable to Parent	$-85,480	$17,898	$9,880	$-28,220
Net Income (Loss) Available to Common Stockholders, Basic	$-92,933	$12,085	$5,027	$-22,922

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$116,539	$125,406	$166,132	$199,255
Liabilities	$38,065	$27,004	$23,850	$34,336
Assets, Current	$57,221	$64,786	$102,369	$122,072
Cash and Cash Equivalents, at Carrying Value	$33,509	$11,813	$37,070	$43,287
Cash	$33,500	—	—	$33,500
Short-term Investments	—	$14,858	$15,355	$14,058
Accounts Receivable, after Allowance for Credit Loss, Current	—	$19,589	$31,078	$27,760
Inventory, Net	$4,281	$6,337	—	$11,428
Other Assets, Current	$1,045	$1,436	$1,489	$1,489
Property, Plant and Equipment, Net	$23,288	$23,880	$23,599	$27,284
Property, Plant and Equipment, Gross	$27,553	$29,479	$31,175	$39,984
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$4,265	$5,599	$7,576	$12,700
Operating Lease, Right-of-Use Asset	$489	$1,818	$1,131	$3,279
Deferred Tax Assets, Net of Valuation Allowance	$4,695	$5,619	$6,873	$6,873
Other Assets, Noncurrent	$995	$3,030	$2,492	$7,344
Liabilities, Current	$20,047	$19,516	$18,286	$28,663
Accounts Payable, Current	$355	$108	$124	$1,236
Stockholders' Equity Attributable to Parent	$-15,828	$63,319	$106,031	$107,928

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Cash Provided by (Used in) Operating Activities	$25,892	$-3,641	$1,010	$-14,497
Net Cash Provided by (Used in) Investing Activities	$-19,760	$-19,884	$-474	$7,303
Net Cash Provided by (Used in) Financing Activities	$2,500	$2,102	$24,378	$696
Depreciation, Depletion and Amortization	$1,074	$1,549	$2,481	$3,460
Payments to Acquire Property, Plant, and Equipment	$8,517	$2,315	$1,190	$1,252
Proceeds from Issuance of Common Stock	—	$773	—	$773

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("GYRE","financials")

Full statements spill as a table. For one cell: =jivedata("GYRE","Revenue") or =jivedata("GYRE","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.